Europe, while there is a separate study
using a Dana pump taking place that
aims to submit for FDA compliance in the
US (currently on hold due to Covid-19).
FDA approval submission is still part of
the company's development plans.
The data visuals from the Diabeloop
system can be viewed on a cloud-based
platform, called YourLoops, and shared
with those in the user's care group,
including family members, partners or
Diabeloop now has offices in Germany,
a priority country for its plans. Earlier this
year it also announced the conclusion
of an agreement with global healthcare
leader Terumo and a partnership with
Roche Diabetes Care. Marc Julien, coCEO of Diabeloop comments, "We
very excited about these strong and
reliable partnerships. They are key to
expanding our position in therapeutic
artificial intelligence not just in France, but
internationally - particularly in Europe."
Diabeloop's Marc Julien
Strong and reliable
key to expanding our
position in therapeutic
- Marc Julien
The Diabeloop system components,
including the YourLoops platform.
BELOW: The Diabeloop handset.